Format

Send to

Choose Destination
Blood. 2011 May 5;117(18):4852-4. doi: 10.1182/blood-2010-10-310995. Epub 2011 Mar 15.

A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.

Author information

1
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Abstract

A20, a negative regulator of NF-κB, has been implicated as a tumor suppressor gene in multiple types of B-cell lymphoma. AIDS-related lymphomas (ARLs) are high-grade B-cell lymphomas that are frequently associated with EBV infection. We examined a panel of ARLs for A20 alterations. FISH showed A20 deletion in 6 of 33 cases (18%). A20 mutations were found in 3 of 19 cases (16%), including 2 cases with deletions of the comple-mentary allele. Immunohistochemistry showed the absence of A20 protein in 7 of 55 samples (13%). In contrast to reports in Hodgkin lymphoma in which EBV infection and A20 alteration are mutually exclusive, A20 inactivation was observed in both EBV(+) and EBV(-) cases. The EBV latent membrane protein 1, which activates NF-κB, was not expressed in 12 of 13 cases with A20 loss. In ARLs loss of A20 may be an alternative mechanism of NF-κB activation in the absence of latent membrane protein 1 expression.

PMID:
21406721
PMCID:
PMC3100694
DOI:
10.1182/blood-2010-10-310995
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center